While calls to “start over again” and “blow up the whole model” seasoned today’s meeting of the Senate Finance Committee investigating the pharmacy benefit management industry, most lawmakers focused on looking at new approaches to fixing a flawed drug pricing system.
top of page
bottom of page
Bình luận